SCHEMBL3310067

SCHEMBL3310067

O=C(O)/C(O)=C\C(=O)c1ccc(Br)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
CYP1B1 Q16678 1/20 0.50
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
ALDH1A1 P00352 8/20 0.47
LMNA P02545 3/20 0.47
ALOX12 P18054 2/20 0.47
USP2 O75604 1/20 0.47
RAB9A P51151 2/20 0.47
RECQL P46063 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 4/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
NPC1 O15118 1/20 0.43
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3310061 1.00 CYP1A2 (0.55) CYP1A2CYP1B1CES2CES1ALDH1A1
SCHEMBL3310076 1.00 CYP1A2 (0.55) CYP1A2CYP1B1CES2CES1ALDH1A1
SCHEMBL3305717 0.80 NFE2L2 (0.64) CYP1B1CES2CES1ALDH1A1LMNA
SCHEMBL3305722 0.80 NFE2L2 (0.64) CYP1B1CES2CES1ALDH1A1LMNA
SCHEMBL3305728 0.80 NFE2L2 (0.64) CYP1B1CES2CES1ALDH1A1LMNA
SCHEMBL3310545 0.80 ALDH1A1 (0.51) CYP1A2CYP1B1ALDH1A1LMNAALOX12
SCHEMBL3310551 0.80 ALDH1A1 (0.51) CYP1A2CYP1B1ALDH1A1LMNAALOX12
SCHEMBL3678944 0.79 ALOX15 (0.52) CYP1A2CYP1B1CES2CES1ALDH1A1
SCHEMBL3678941 0.79 ALOX15 (0.52) CYP1A2CYP1B1CES2CES1ALDH1A1
SCHEMBL8105255 0.79 MAPT (0.58) CYP1A2CES2CES1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US claimed
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US disclosed
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US disclosed
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof TEXAS A&M UNIVERSITY SYSTEM, THE 2010-05-06 US disclosed
WO-2010047774-A2 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS MALATE SYNTHASE, METHODS OF MARKING AND USES THEREOF THE TEXAS A & M UNIVERSITY SYSTEM (US) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof ME3, ME1, MDH1 CYP1A2 697/4885CYP1B1 864/4885CES2 1884/4885
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof ME3, ME1, MDH1 CYP1A2 697/4885CYP1B1 864/4885CES2 1884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.